UB Paderborn / Katalog / Suche / in CDI

Plasma profiles of inflammatory cytokines in children with moderate to severe traumatic brain injury: a prospective cohort study

European journal of pediatrics, 2024-08, Vol.183 (8), p.3359-3368

2024

Volltextzugriff (PDF)

Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer

European urology oncology, 2024-08, Vol.7 (4), p.751-759

2024

Volltextzugriff (PDF)

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer

The Prostate, 2024-07, Vol.84 (10), p.954-958

2024

Volltextzugriff (PDF)

Effect of in vivo culture conditions on the proliferation and differentiation of rat adipose-derived stromal cells

Mechanisms of ageing and development, 2024-06, Vol.219, p.111935-111935, Article 111935

2024

Volltextzugriff (PDF)

The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide

Clinical cancer research, 2024-03, Vol.30 (6), p.1152

2024

Volltextzugriff (PDF)

The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5060-5060

2023

Volltextzugriff (PDF)

RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients

Materials today bio, 2022-12, Vol.17, p.100474-100474, Article 100474

2022

Volltextzugriff (PDF)

GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression

Biochimica et biophysica acta. Molecular basis of disease, 2022-01, Vol.1868 (1), p.166268-166268, Article 166268

2022

Volltextzugriff (PDF)

AR Splicing Variants and Resistance to AR Targeting Agents

Cancers, 2021-05, Vol.13 (11), p.2563

2021

Volltextzugriff (PDF)

Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations

Prostate cancer and prostatic diseases, 2020-09, Vol.23 (3), p.381-397

2020

Volltextzugriff (PDF)

Androgen receptor variant-driven prostate cancer II: advances in clinical investigation

Prostate cancer and prostatic diseases, 2020-09, Vol.23 (3), p.367-380

2020

Volltextzugriff (PDF)

Abstract 5365: Profiling circulating tumor cell RNA from a large blood screening volume: A pilot study using diagnostic leukapheresis followed by the NanoString low RNA input nCounter assay

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5365-5365

2020

Volltextzugriff (PDF)

The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer

Nature communications, 2020-06, Vol.11 (1), p.2689-14, Article 2689

2020

Volltextzugriff (PDF)

Identification of Biomarkers of Sepsis-Associated Acute Kidney Injury in Pediatric Patients Based on UPLC-QTOF/MS

Inflammation, 2020-04, Vol.43 (2), p.629-640

2020

Volltextzugriff (PDF)

Abstract 1383: Isolating circulating tumor cells from a large screening blood volume: A pilot study using diagnostic leukapheresis

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1383-1383

2019

Volltextzugriff (PDF)

CuZnCoOx multifunctional catalyst for in situ hydrogenation of 5-hydroxymethylfurfural with ethanol as hydrogen carrier

Journal of catalysis, 2019-05, Vol.373 (C), p.314-321

2019

Volltextzugriff (PDF)

Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy–naïve salivary duct carcinomas

Human pathology, 2019-02, Vol.84, p.173-182

2019

Volltextzugriff (PDF)

Catalytic in-situ hydrogenation of 5-hydroxymethylfurfural to 2,5-dimethylfuran over Cu-based catalysts with methanol as a hydrogen donor

Applied catalysis. A, General, 2019-01, Vol.570, p.245-250

2019

Volltextzugriff (PDF)

Quantitative proteomics reveals the mechanisms of hydrogen-conferred protection against hyperoxia-induced injury in type II alveolar epithelial cells

Experimental lung research, 2018-11, Vol.44 (10), p.464-475

2018

Volltextzugriff (PDF)

Efficient and stable Cu-Ni/ZrO^sub 2^ catalysts for in situ hydrogenation and deoxygenation of oleic acid into heptadecane using methanol as a hydrogen donor

Fuel (Guildford), 2018-10, Vol.230, p.211

2018

Volltextzugriff (PDF)

Efficient and stable Cu-Ni/ZrO2 catalysts for in situ hydrogenation and deoxygenation of oleic acid into heptadecane using methanol as a hydrogen donor

Fuel (Guildford), 2018-10, Vol.230, p.211-217

2018

Volltextzugriff (PDF)

Abstract B070: Epithelial-marker absent and disease-marker specific circulating and disseminated tumor cells are rarely detected in men with localized prostate cancer

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16_Supplement), p.B070-B070

2018

Volltextzugriff (PDF)

Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide

European urology, 2018-08, Vol.74 (2), p.218-225

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Plasma profiles of inflammatory cytokines in children with moderate to severe traumatic brain injury: a prospective cohort study

Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer

Effect of in vivo culture conditions on the proliferation and differentiation of rat adipose-derived stromal cells

The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide

The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide

RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients

GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression

AR Splicing Variants and Resistance to AR Targeting Agents

Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations

Androgen receptor variant-driven prostate cancer II: advances in clinical investigation

Abstract 5365: Profiling circulating tumor cell RNA from a large blood screening volume: A pilot study using diagnostic leukapheresis followed by the NanoString low RNA input nCounter assay

The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer

Identification of Biomarkers of Sepsis-Associated Acute Kidney Injury in Pediatric Patients Based on UPLC-QTOF/MS

Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer

Abstract 1383: Isolating circulating tumor cells from a large screening blood volume: A pilot study using diagnostic leukapheresis

CuZnCoOx multifunctional catalyst for in situ hydrogenation of 5-hydroxymethylfurfural with ethanol as hydrogen carrier

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy–naïve salivary duct carcinomas

Catalytic in-situ hydrogenation of 5-hydroxymethylfurfural to 2,5-dimethylfuran over Cu-based catalysts with methanol as a hydrogen donor

Quantitative proteomics reveals the mechanisms of hydrogen-conferred protection against hyperoxia-induced injury in type II alveolar epithelial cells

Efficient and stable Cu-Ni/ZrO^sub 2^ catalysts for in situ hydrogenation and deoxygenation of oleic acid into heptadecane using methanol as a hydrogen donor

Efficient and stable Cu-Ni/ZrO2 catalysts for in situ hydrogenation and deoxygenation of oleic acid into heptadecane using methanol as a hydrogen donor

Abstract B070: Epithelial-marker absent and disease-marker specific circulating and disseminated tumor cells are rarely detected in men with localized prostate cancer

Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide

Suchergebnisse filtern